Abbott India has posted robust financial results for the fourth quarter and full fiscal year ending March 31, 2025, driven by consistent revenue growth and operational efficiency. The pharmaceutical major reported a 28% year-on-year increase in Q4 net profit to Rs. 367 crore, supported by a rise in sales to Rs. 1,605 crore. For the full fiscal year, net profit climbed to Rs. 1,414 crore, with annual revenues reaching Rs. 6,409 crore. The board has proposed a final dividend of Rs. 475 per share.
